Follow
Tareq Juratli
Tareq Juratli
Associate Professor of Neurosurgery, Carl Gustav Carus University Hospital, Technical University
Verified email at ukdd.de
Title
Cited by
Cited by
Year
Current status of local therapy in malignant gliomas—a clinical review of three selected approaches
TA Juratli, G Schackert, D Krex
Pharmacology & therapeutics 139 (3), 341-358, 2013
1672013
Early hemorrhagic progression of traumatic brain contusions: frequency, correlation with coagulation disorders, and patient outcome: a prospective study
TA Juratli, B Zang, RJ Litz, KH Sitoci, U Aschenbrenner, B Gottschlich, ...
Journal of neurotrauma 31 (17), 1521-1527, 2014
1382014
IDH mutations as an early and consistent marker in low-grade astrocytomas WHO grade II and their consecutive secondary high-grade gliomas
TA Juratli, M Kirsch, K Robel, S Soucek, K Geiger, R von Kummer, ...
Journal of neuro-oncology 108, 403-410, 2012
1332012
Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases
PN Harter, S Bernatz, A Scholz, PS Zeiner, J Zinke, M Kiyose, S Blasel, ...
Oncotarget 6 (38), 40836, 2015
1282015
Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas
TA Juratli, C Thiede, MVA Koerner, SS Tummala, D Daubner, ...
Oncotarget 8 (65), 109228, 2017
1022017
Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis
C Mirian, AK Duun-Henriksen, T Juratli, F Sahm, S Spiegl-Kreinecker, ...
Journal of Neurology, Neurosurgery & Psychiatry 91 (4), 378-387, 2020
972020
The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas
TA Juratli, M Kirsch, K Geiger, B Klink, E Leipnitz, T Pinzer, S Soucek, ...
Journal of neuro-oncology 110, 325-333, 2012
972012
Radiographic assessment of contrast enhancement and T2/FLAIR mismatch sign in lower grade gliomas: correlation with molecular groups
TA Juratli, SS Tummala, A Riedl, D Daubner, S Hennig, T Penson, A Zolal, ...
Journal of neuro-oncology 141, 327-335, 2019
812019
DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome
TA Juratli, D McCabe, N Nayyar, EA Williams, IM Silverman, SS Tummala, ...
Acta neuropathologica 136, 779-792, 2018
792018
TERT Promoter Mutation Detection in Cell-Free Tumor-Derived DNA in Patients with IDH Wild-Type Glioblastomas: A Pilot Prospective Study
TA Juratli, S Stasik, A Zolal, C Schuster, S Richter, D Daubner, MA Juratli, ...
Clinical Cancer Research 24 (21), 5282-5291, 2018
732018
Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic
EA Williams, S Santagata, H Wakimoto, GM Shankar, FG Barker, R Sharaf, ...
Acta neuropathologica communications 8, 1-10, 2020
722020
Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations
TA Juratli, PS Jones, N Wang, M Subramanian, SJB Aylwin, Y Odia, ...
Cancer 125 (17), 2910-2914, 2019
662019
Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas
MR Strickland, CM Gill, N Nayyar, MR D'Andrea, C Thiede, TA Juratli, ...
Journal of neurosurgery 127 (2), 438-444, 2017
612017
Peripheral nerve field stimulation for trigeminal neuralgia, trigeminal neuropathic pain, and persistent idiopathic facial pain
J Klein, S Sandi-Gahun, G Schackert, TA Juratli
Cephalalgia 36 (5), 445-453, 2016
602016
Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme
A Seidlitz, T Siepmann, S Löck, T Juratli, M Baumann, M Krause
Radiation Oncology 10, 1-10, 2015
532015
Genotype-targeted local therapy of glioma
GM Shankar, AR Kirtane, JJ Miller, H Mazdiyasni, J Rogner, T Tai, ...
Proceedings of the National Academy of Sciences 115 (36), E8388-E8394, 2018
492018
Accelerated progression of IDH mutant glioma after first recurrence
JJ Miller, F Loebel, TA Juratli, SS Tummala, EA Williams, TT Batchelor, ...
Neuro-oncology 21 (5), 669-677, 2019
462019
IDH1 mutation in human glioma induces chemical alterations that are amenable to optical Raman spectroscopy
O Uckermann, W Yao, TA Juratli, R Galli, E Leipnitz, M Meinhardt, E Koch, ...
Journal of Neuro-Oncology 139, 261-268, 2018
452018
Real-Time Label-Free Embolus Detection Using In Vivo Photoacoustic Flow Cytometry
MA Juratli, YA Menyaev, M Sarimollaoglu, ER Siegel, DA Nedosekin, ...
PLoS One 11 (5), e0156269, 2016
412016
A clinical rule for preoperative prediction of BRAF mutation status in craniopharyngiomas
S Fujio, TA Juratli, K Arita, H Hirano, Y Nagano, T Takajo, K Yoshimoto, ...
Neurosurgery 85 (2), 204-210, 2019
392019
The system can't perform the operation now. Try again later.
Articles 1–20